Carregant...
New Verse for a Familiar Song: Small Molecule Inhibitors for MET exon 14 Skipping Non‐Small Cell Lung Cancer
MET exon 14 skipping alterations (METex14) represent one of the newest discovered driver oncogene alterations for non‐small cell lung cancer (NSCLC), which serve to define a distinct elderly patient population. New challenges in detection and treatment have emerged. In the last 15 years, the success...
Guardat en:
| Publicat a: | Oncologist |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Inc.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7543381/ https://ncbi.nlm.nih.gov/pubmed/33400286 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2020-0760 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|